Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» U.S. FDA knocks back Novartis copy of Amgen's drug Neulasta
U.S. FDA knocks back Novartis copy of Amgen's drug Neulasta
U.S. FDA knocks back Novartis copy of Amgen's drug Neulasta
Submitted by
admin
on July 19, 2016 - 10:18am
Source:
Yahoo/Reuters
News Tags:
FDA
Novartis
biosimilars
Amgen
Neulasta
Headline:
U.S. FDA knocks back Novartis copy of Amgen's drug Neulasta
Do Not Allow Advertisers to Use My Personal information
